DXCM Filing
4Filing Date: Jun 1, 2026

DEXCOM INC (DXCM) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001093557-26-000120open_in_new
Total Value$0
Trades1
Insiders1

Transaction Details

Osterloh Albert Frederick IV
Director·Direct
Grant · Acquire
Common Stock
Shares+1.63K
Price$0.00
Total Value$0
Shares Owned After8.69K
Transaction DateMay 28, 2026
Footnotes ▸

The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. | Included in this number are 8,691 unvested restricted stock units, 1,630 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 7,061 of which were granted on February 26, 2026 and shall vest through February 26, 2029.

Post-Transaction Holdings

Osterloh Albert Frederick IV
SecuritySharesChange
Common Stock8.69K+1.63K (23.08%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-28 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: DEXCOM INC (DXCM) CIK: 0001093557 --- Reporting Owner --- Name: Osterloh Albert Frederick IV CIK: 0002111108 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-28 | Code: A (Grant or award) Shares: +1,630 | Price: $0.00 Shares Owned After: 8,691 | Ownership: D (Direct) Footnotes: [F1] The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. [F2] Included in this number are 8,691 unvested restricted stock units, 1,630 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 7,061 of which were granted on February 26, 2026 and shall vest through February 26, 2029. --- Footnotes (Complete Index) --- F1: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2: Included in this number are 8,691 unvested restricted stock units, 1,630 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 7,061 of which were granted on February 26, 2026 and shall vest through February 26, 2029. --- Signature --- /s/ /s/ Jereme M. Sylvain, as Attorney-in-Fact for Albert Frederick (Rick) Osterloh IV (2026-06-01)

keid AI analysis is for reference only and does not constitute investment advice.